Kiel, K., & Goldschmidt, H. (1999). Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myeloma. Autologous blood and marrow transplantation.
Chicago-Zitierstil (17. Ausg.)Kiel, Katja, und Hartmut Goldschmidt. "Pretreatment with Alkylating Agents Predicts for Tumor Cell Content and CD34(+) Stem Cell Yield in Leukapheresis Products of Patients with Multiple Myeloma." Autologous Blood and Marrow Transplantation 1999.
MLA-Zitierstil (9. Ausg.)Kiel, Katja, und Hartmut Goldschmidt. "Pretreatment with Alkylating Agents Predicts for Tumor Cell Content and CD34(+) Stem Cell Yield in Leukapheresis Products of Patients with Multiple Myeloma." Autologous Blood and Marrow Transplantation, 1999.